SEC Info℠ | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 3/30/12 Weikang Bio-Tech Group Co., Inc. 10-K 12/31/11 44:2.3M Toppan Merrill/FA |
Document/Exhibit Description Pages Size 1: 10-K Annual Report HTML 474K 2: EX-10.12 Material Contract HTML 15K 3: EX-14.1 Code of Ethics HTML 26K 4: EX-23.1 Consent of Experts or Counsel HTML 14K 5: EX-23.2 Consent of Experts or Counsel HTML 13K 6: EX-31.1 Certification -- §302 - SOA'02 HTML 19K 7: EX-31.2 Certification -- §302 - SOA'02 HTML 19K 8: EX-32.1 Certification -- §906 - SOA'02 HTML 15K 9: EX-32.2 Certification -- §906 - SOA'02 HTML 15K 28: R1 Document and Entity Information HTML 45K 21: R2 Consolidated Balance Sheets HTML 128K 26: R3 Consolidated Balance Sheets (Parenthetical) HTML 25K 30: R4 Consolidated Statements of Income and HTML 99K Comprehensive Income 41: R5 Consolidated Statements of Cash Flows HTML 111K 22: R6 Consolidated Statements of Stockholders' Equity HTML 64K 25: R7 Organization and Description of Business HTML 26K 20: R8 Summary of Significant Accounting Policies HTML 65K 18: R9 Accounts Receivable HTML 22K 42: R10 Advances to Suppliers and Other Receivables HTML 17K 32: R11 Inventory HTML 20K 31: R12 Property and Equipment, net HTML 23K 36: R13 Construction in Progress HTML 15K 37: R14 Intangible Assets HTML 21K 35: R15 Related Party Transactions HTML 20K 38: R16 Major Customers and Vendors HTML 15K 27: R17 Unearned Revenue HTML 18K 29: R18 Taxes Payable HTML 17K 34: R19 Other Payables and Accrued Expenses HTML 18K 44: R20 Deferred Tax Asset (Liability) HTML 19K 39: R21 Income Taxes HTML 26K 23: R22 Stockholders' Equity HTML 62K 33: R23 Statutory Reserves HTML 18K 24: R24 Contingencies HTML 16K 16: R25 Goodwill HTML 16K 40: R26 Subsequent Event HTML 16K 43: XML IDEA XML File -- Filing Summary XML 53K 19: EXCEL IDEA Workbook of Financial Reports (.xls) XLS 212K 10: EX-101.INS XBRL Instance -- wkbt-20111231 XML 314K 12: EX-101.CAL XBRL Calculations -- wkbt-20111231_cal XML 105K 13: EX-101.DEF XBRL Definitions -- wkbt-20111231_def XML 300K 14: EX-101.LAB XBRL Labels -- wkbt-20111231_lab XML 341K 15: EX-101.PRE XBRL Presentations -- wkbt-20111231_pre XML 348K 11: EX-101.SCH XBRL Schema -- wkbt-20111231 XSD 60K 17: ZIP XBRL Zipped Folder -- 0001144204-12-018721-xbrl Zip 56K
Exhibit 14.1
WEIKANG BIO-TECHNOLOGY GROUP CO., INC. CODE OF ETHICS
Introduction
The Board of Directors of Weikang Bio-technology Group Co., Inc. has adopted this code of ethics (the “Code”), which is applicable to all directors, officers and employees to:
Promote honest and ethical conduct, including the ethical handling of actual or apparent conflicts of interest between personal and professional relationships; promote the full, fair, accurate, timely and understandable disclosure in reports and documents that the Company files with, or submits to, the SEC, as well as in other; public communications made by or on behalf of the Company; promote compliance with applicable governmental laws, rules and regulations; deter wrongdoing; and require prompt internal reporting of breaches of, and accountability for adherence to, this Code. This Code may be amended only by resolution of the Company’s Board of Directors. In this Code, references to the “Company” means Weikang Bio-technology Group Inc., and, in appropriate context, the Company’s subsidiaries.
Honest, Ethical and Fair Conduct
Each person owes a duty to the Company to act with integrity. Integrity requires, among other things, being honest, fair and candid. Deceit, dishonesty and subordination of principle are inconsistent with integrity.
Service to the Company never should be subordinated to personal gain and advantage.
Each person must:
Act with integrity, including being honest and candid while still maintaining the confidentiality of the Company’s information where required or in the Company’s interests;
Observe all applicable governmental laws, rules and regulations;
Comply with the requirements of applicable accounting and auditing standards, as well as Company policies, in the maintenance of a high standard of accuracy and completeness in the Company’s financial records and other business-related information and data;
Adhere to a high standard of business ethics and not seek competitive advantage through unlawful or unethical business practices;
Deal fairly with the Company’s customers, suppliers, competitors and employees;
C:
Refrain from taking advantage of anyone through manipulation, concealment, abuse of privileged information, misrepresentation of material facts or any other unfair-dealing practice;
Protect the assets of the Company and ensure their proper use.;
Refrain from taking for themselves personally opportunities that are discovered through the use of corporate assets or using corporate assets, information or position for general personal gain outside the scope of employment with the Company;
Avoid conflicts of interest wherever possible;
Anything that would be a conflict for a person subject to this Code also will be a conflict if it is related to a member of his or her family or a close relative. Examples of conflict of interest situations include, but are not limited to, the following: any significant ownership interest in any supplier or customer; any consulting or employment relationship with any customer, supplier or competitor; any outside business activity that detracts from an individual’s ability to devote appropriate time and attention to his or her responsibilities with the Company; the receipt of any money, non-nominal gifts or excessive entertainment from any company with which the Company has current or prospective business dealings; being in the position of supervising, reviewing or having any influence on the job evaluation, pay or benefit of any close relative; selling anything to the Company or buying anything from the Company, except on the same terms and conditions as comparable officers or directors are permitted to so purchase or sell; and any other circumstance, event, relationship or situation in which the personal interest of a person subject to this Code interferes, or even appears to interfere with the interests of the Company as a whole.
Disclosure
The Company strives to ensure that the contents of and the disclosures in the reports and documents that the Company files with the Securities and Exchange Commission (the “SEC”) and other public communications shall be full, fair, accurate, timely and understandable in accordance with applicable disclosure standards, including standards of materiality, where appropriate. Each person must; not knowingly misrepresent, or cause others to misrepresent, facts about the Company to others, whether within or outside the Company, including to the Company’s independent auditors, governmental regulators, self-regulating organizations and other governmental officials, as appropriate; and in relation to his or her area of responsibility, properly review and critically analyze proposed disclosure for accuracy and completeness. In addition to the foregoing, the Chief Executive Officer of Company and each subsidiary of Company, the Chief Financial Officer of Parent and each subsidiary, and each other person that typically is involved in the financial reporting of the Company must familiarize himself or herself with the disclosure requirements applicable to the Company as well as the business and financial operations of the Company. Each person must promptly bring to the attention of the Chairman of the Audit Committee of the Company’s Board of Directors any information he or she may have concerning (a) significant deficiencies in the design or operation of internal and/or disclosure controls which could adversely affect the Company’s ability to record, process, summarize and report financial data or (b) any fraud, whether or not material, that involves management or other employees who have a significant role in the Company’s financial reporting, disclosures or internal controls.
C:
Compliance
It is the Company’s obligation and policy to comply with all applicable governmental laws, rules and regulations. It is the personal responsibility of each person to, and each person must, adhere to the standards and restrictions imposed by those laws, rules and regulations, including those relating to accounting and auditing matters.
Reporting and Accountability
The Audit Committee of the Board of Directors of the Company is responsible for applying this Code to specific situations in which questions are presented to it and has the authority to interpret this Code in any particular situation. Any person who becomes aware of any existing or potential breach of this Code is required to notify the Chairman of the Audit Committee promptly. Failure to do so is itself a breach of this Code. Specifically, each person must: Notify the Chairman of the Audit Committee promptly of any existing or potential violation of this Code; Not retaliate against any other person for reports of potential violations that are made in good faith. The Company will follow the following procedures in investigating and enforcing this Code and in reporting on the Code: The Audit Committee will take all appropriate action to investigate any breaches reported to it. If the Audit Committee determines that a breach has occurred, it will inform the Board of Directors. Upon being notified that a breach has occurred, the Board will take or authorize such disciplinary or preventive action as it deems appropriate, after consultation with the Audit Committee and General Counsel, up to and including dismissal or, in the event of criminal or other serious violations of law, notification of the SEC or other appropriate law enforcement authorities. No person following the above procedure shall, as a result of following such procedure, be subject by the Company or any officer or employee thereof to discharge, demotion suspension, threat, harassment or, in any manner, discrimination against such person in terms and conditions of employment.
Waivers and Amendments
Any waiver (defined below) or an implicit waiver (defined below) from a provision of this Code for the principal executive officer, principal financial officer, principal accounting officer or controller, and persons performing similar functions or any amendment (as defined below) to this Code is required to be disclosed in the Company’s Annual Report on Form 10-K or in a Current Report on Form 8-K filed with the SEC. A “waiver” means the approval by the Company’s Board of Directors of a material departure from a provision of the Code. An “implicit waiver” means the Company’s failure to take action within a reasonable period of time regarding a material departure from a provision of the Code that has been made known to an executive officer of the Company. An “amendment” means any amendment to this Code other than minor technical, administrative or other non-substantive amendments hereto. All persons should note that it is not the Company’s intention to grant or to permit waivers from the requirements of this Code. The Company expects full compliance with this Code.
C:
Other Policies and Procedures
Any other policy or procedure set out by the Company in writing or made generally known to employees, officers or directors of the Company prior to the date hereof or hereafter are separate requirements and remain in full force and effect.
Inquiries
All inquiries and questions in relation to this Code or its applicability to particular people or situations should be addressed to the Director of Administration.
C: